B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis

B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis

The effect of rituximab on B cell and immunoglobulin production after therapeutic apheresis has not been studied in ABO-incompatible renal transplant patients. Methods: Twenty consecutive ABO-incompatible renal transplant patients receiving rituximab induction and double filtration plasmapheresis we...

Full description

Bibliographic Details
Main Authors:	Meng-Kun Tsai, Ming-Shiou Wu, Ching-Yao Yang, Chih-Yuan Lee, Chi-Chuan Yeh, Rey-Heng Hu, Po-Huang Lee, Hong-Shiee Lai
Format:	Article
Language:	English
Published:	Elsevier 2015-04-01
Series:	Journal of the Formosan Medical Association
Subjects:	B cells immunosuppressants renal transplantation rituximab
Online Access:	http://www.sciencedirect.com/science/article/pii/S092966461300003X

Similar Items

Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation
by: Hamza Naciri Bennani, et al.
Published: (2018-07-01)

Overcoming high pre-transplant isoagglutinin titers using high-dose intravenous immunoglobulin, salvage plasmapheresis, and booster rituximab without splenectomy in ABO-incompatible living donor liver transplantation: a case report
by: Hyung Hwan Moon
Published: (2022-06-01)

Successful pregnancy after in vitro fertilization in an ABO-incompatible kidney transplant recipient receiving rituximab: a case report
by: Akihiro Kosoku, et al.
Published: (2019-06-01)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
by: Suk Kyun Hong, et al.
Published: (2023-09-01)

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
by: Diego Curtò, et al.
Published: (2021-06-01)

Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01)

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
by: Myung Jin Oh, et al.
Published: (2013-03-01)

Role of double-filtration plasmapheresis in ABO- and human leukocyte antigen-incompatible kidney transplant
by: Smriti Sinha, et al.
Published: (2022-01-01)

Rituximab in glomerular diseases: a case series and narrative review
by: Inês Duarte, et al.
Published: (2021-12-01)

Successful treatment with rituximab and plasmapheresis of renal involvement of eosinophilic granulomatosis with polyangiitis
by: Ryuichi Yoshii, et al.
Published: (2023-02-01)

Current Perspectives in ABO-Incompatible Kidney Transplant
by: Maritati F, et al.
Published: (2022-05-01)

Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months
by: Kamran Balighi, et al.
Published: (2019-05-01)

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
by: Wei-Chen Lee, et al.
Published: (2021-12-01)

Clinical analysis of rituximab for adult refractory primary membranous nephropathy
by: FENG Linhong, et al.
Published: (2023-03-01)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
by: Vagiani Perifani, et al.
Published: (2021-12-01)

Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review
by: Soo-Jee Jeon, et al.
Published: (2022-07-01)

Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia
by: Ben Koszegi, et al.
Published: (2023-03-01)

Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients
by: F Ahmadi, et al.
Published: (2019-07-01)

Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience
by: Moustafa S. Alhamadh, et al.
Published: (2023-10-01)

Immunosuppression with Rituximab in Glomerular Diseases in Adults: Who, How and When?
by: Raquel Pereira Sousa Pinto, et al.
Published: (2023-06-01)

Successful treatment of idiopathic retinal vasculitis with rituximab in two patients
by: Atitaya Apivatthakakul, et al.
Published: (2023-06-01)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
by: Fatemeh Saffari, et al.
Published: (2022-01-01)

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
by: Jongwook Oh, et al.
Published: (2020-01-01)

Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab
by: Hock Gin Teo, et al.
Published: (2022-01-01)

Rituximab resistance in ITP and beyond
by: Zhengrui Xiao, et al.
Published: (2023-07-01)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
by: Mohamad Y. Khatib, et al.
Published: (2021-02-01)

Unexpected positive effects of rituximab and corticosteroids on COVID-19 in a patient suffering from granulomatosis with polyangiitis
by: Mansour Salesi, et al.
Published: (2021-01-01)

Efficacy of everolimus in ABO-incompatible kidney transplantation: a retrospective study
by: Tsujimura K, et al.
Published: (2017-09-01)

Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis
by: Atsuyuki Mitsuishi, et al.
Published: (2023-10-01)

Use of rituximab in pediatric patients with steroidresistant nephrotic syndrome. A single center study
by: Serna-Higuita, Lina María, et al.
Published: (2015-01-01)

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
by: Faisal Musa, et al.
Published: (2015-04-01)

Seroconversion of red blood cell antibody in ABO-incompatible living donor liver transplantation -a case report-
by: Eun Kyung Lee, et al.
Published: (2020-06-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab
by: Seolah Lee, et al.
Published: (2023-01-01)

Rhodococcus erythropolis Encephalitis in Patient Receiving Rituximab
by: Satish R. Bagdure, et al.
Published: (2012-08-01)

Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome
by: Arata Osanami, et al.
Published: (2022-09-01)

Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
by: João Marcello de Araujo-Neto, et al.
Published: (2022-08-01)

Living donor transplant options in end-stage renal disease patients with ABO incompatibility
by: Santosh S Waigankar, et al.
Published: (2013-01-01)

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022-03-01)

Rituximab use in adult glomerulopathies and its rationale
by: Joana Eugénio Santos, et al.
Published: (2019-12-01)